Why the study?
The study sought to assess the prevalence of arterial hypertension, the need for antihypertensive therapy, and therapy efficacy in Russia according to the 2017 ACC/AHA guideline.
Does the application of the 2017 ACC/AHA guidelines compared to ESC guidelines change the prevalence of arterial hypertension and need for therapy in the Russian population?
Population
20 607 Russian residents aged 25-65 years across 12 regions
Comparison
2017 ACC/AHA hypertension criteria vs 2013 and 2018 ESC criteria
Design
Multicenter cross-sectional epidemiological study
Key result
Applying the 2017 ACC/AHA guidelines to a Russian population aged 25-65 years increased the diagnosed prevalence of arterial hypertension to 72.1%, compared to 50.2% using European guidelines.
Authors
Loading...
Applying 2017 ACC/AHA criteria would expand AH diagnoses and intensify treatment needs in Russia; leaves open outcome benefits versus European thresholds.
Cross-Sectional (n=20,607)
Yes
Does the application of the 2017 ACC/AHA guidelines compared to ESC guidelines change the prevalence of arterial hypertension and need for therapy in the Russian population?
Absolute Event Rate: 72.1% vs 50.2%
Adopting the 2017 ACC/AHA hypertension guidelines in the Russian Federation would substantially increase the diagnosed prevalence of hypertension and the need for treatment intensification compared to European guidelines.
Ерина et al. (2019) conducted a cross-sectional in Arterial hypertension (n=20,607). 2017 ACC/AHA guidelines criteria vs. European Society of Cardiology (2013, 2018) guidelines criteria was evaluated on Prevalence of arterial hypertension. Applying the 2017 ACC/AHA guidelines to a Russian population aged 25-65 years increased the diagnosed prevalence of arterial hypertension to 72.1%, compared to 50.2% using European guidelines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: